Kliniska prövningar

Listan upptar endast kliniskt kontrollerade studier där tumörregistret aktivt medverkar med design, randomisering uppföljning eller monitorering.

■ Studier med pågående patientrekrytering
♦ Studier med aktiv uppföljning, monitorering och/eller analys
• Avslutade studier

Colorektal cancer
■ ACT (ML 19033) Metastaserande colorektal cancer
• Adjuvant behandling (1993-1996)
• Preoperativ strålbehandling (1987-1990)

Lungcancer
• Oxigenestudie

Malignt melanom
• Excisionsstudie I (1982-1991)
• Excisionsstudie II (1992-2006)
• Kemoterapistudie (1983-1987)
• Kemoterapistudie (1987-1992)

Ben och mjukdelssarkom
■ ISG/SSG III	Lokaliserad Ewing´s sarkom
■ EUROBOSS I	Osteosarkom >40 år
♦ EURAMOS I	Osteosarkom <40 år
■ SSG XX	Non-metastatic high risk soft tissue sarcoma

♦ SSG VIII	The treatment of osteosarcoma
♦ SSG IX	Combined modality therapy in EWS
♦ ISG/SSG I	High-grade osteosarcoma of the extremities
♦ ISG/SSG II	Metastatic and pelvic osteosarcoma
♦ ISG/SSG IV	Metastaserande Ewing´s sarkom
♦ SSG XIV	Treatment research protocol for extremity localized high-grade osteosarcoma
♦ SSG XVIII	GIST, adjuvant studie
■ SSG XXI	GIST, Pazopanib in GISTs refractory to Imatinib and Sunitinib

• SSG I	Adjuvant chemotherapy in STS. (1981-1986)
• SSG II	Combination therapy in OS. (1982-1990)
• SSG IV	Combined modality therapy in EWS. (1984-1990)
• SSG X	Treatment of advanced STS with (VIG). (1991-1995)
• SSG XI	Palliative Oral Trofosfamide in the treatment of metastatic or locally advanced STS. (1994-1996)
• SSG XII	Metastasecetomy and chemotherapy for lungmetastases from STS. (1996-2000)
• SSG XIII	High-risk soft tissue sarcoma of the extremities and trunk wall. (1998-2007)